E3 PreliminaryPreliminaryPEM ?Peer-reviewedMachine draft
Treatment of chronic fatigue and orthostatic intolerance with propranolol.
Wyller, Vegard Bruun, Thaulow, Erik, Amlie, Jan P · The Journal of pediatrics · 2007 · DOI
Quick Summary
This study looked at a teenager with ME/CFS who also experienced dizziness and fainting when standing up (orthostatic intolerance). The doctors treated this teen with propranolol, a blood pressure medication that slows the heart rate. The case suggests that an overactive stress-response system in the nervous system might contribute to ME/CFS symptoms, and that a simple tilt test could help identify patients who might benefit from this type of treatment.
Why It Matters
For many ME/CFS patients, orthostatic symptoms are debilitating and poorly understood. This study offers a testable hypothesis linking these symptoms to abnormal nervous system regulation and suggests an existing medication class worth investigating further in controlled settings.
Observed Findings
- One adolescent patient with ME/CFS and orthostatic intolerance showed clinical improvement when treated with propranolol
- Head-up tilt testing was used to evaluate the patient's cardiovascular response
- The case suggests enhanced sympathetic nervous system activity may be present in some ME/CFS patients
Inferred Conclusions
- Beta-blockers may warrant consideration as a treatment option for ME/CFS patients with concurrent orthostatic intolerance
- Head-up tilt testing could be a useful diagnostic tool for identifying a subset of ME/CFS patients with sympathetic dysregulation
- Abnormal sympathetic nervous system function may contribute to pathophysiology in some ME/CFS cases
Remaining Questions
- Does propranolol provide similar benefit in a larger cohort of ME/CFS patients with orthostatic intolerance?
- What proportion of ME/CFS patients have abnormal sympathetic activation detectable by tilt testing?
- Are there biomarkers that could predict which patients will respond to beta-blocker therapy?
- Does treating orthostatic intolerance improve overall ME/CFS fatigue and functioning?
What This Study Does Not Prove
A single case report cannot prove that propranolol is effective for ME/CFS or that sympathetic overactivity causes the disease in most patients. The improvement observed could reflect placebo response, natural symptom fluctuation, or factors unrelated to the drug's mechanism. Larger, randomized controlled trials are essential before any treatment recommendation can be made.
Tags
Symptom:Orthostatic IntoleranceFatigue
Phenotype:Pediatric
Method Flag:PEM Not DefinedWeak Case DefinitionNo ControlsSmall SampleExploratory Only